Study of V617F JAK2-positive and JAK2-negative patients within 18 families with myeloproliferative disorders (MPD): Disease characteristics and evolution, EPOR and MPL analysis.

被引：0
|
作者：
Bellanne-Chantelot, Christine
Labopin, Myriam
Bellanger, Florence
Chaumarel, Isabelle
Isnard, Franpoise
Casadevall, Nicole
Vainchenker, William
Thomas, Gilles
Najman, Albert
机构：
[1] Univ Paris 06, Dept Genet, APHP St Antoine, Paris, France
[2] INSERM, U790, IGR, Villejuif, France
[3] Dept Canc Epidemiol & Genet, Gaithersburg, MD USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
672
引用
收藏
页码：202A / 202A
页数：1
相关论文
共 50 条
  • [11] A study of JAK2 (V617F) gene mutation in patients with chronic myeloproliferative disorders
    Hamidah, N. H.
    Farisah, N. R.
    Azlinda, A. B.
    Wong, F. L.
    Das, S.
    Fadillah, S. A. W.
    Ainoon, O.
    CLINICA TERAPEUTICA, 2012, 163 (02): : 109 - 113
  • [12] JAK2 V617F mutation and VEGF levels in patients with myeloproliferative disorders
    Bourantas, L.
    Chatzikyriakidou, A.
    Panteli, K.
    Bai, M.
    Bourantas, D. K.
    Tsiara, St.
    Georgiou, I.
    Bourantas, K. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 547 - 548
  • [13] The JAK2 V617F mutation in Philadelphia-negative chronic myeloproliferative disorders
    Stoj, Anastazja
    Rudzki, Zbigniew
    Stachura, Jerzy
    Sacha, Tomasz
    Czekalska, Sylwia
    JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (09) : 1070 - 1071
  • [14] FREQUENCY OF JAK2 EXON 12 MUTATIONS IN JAK2 (V617F) NEGATIVE PATIENTS WITH CHRONIC MYELOPROLIFERATIVE DISORDERS (CMD)
    Bernardi, M.
    Ruggeri, M.
    Albiero, E.
    Madeo, D.
    Rodeghiero, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 294 - 294
  • [15] REAL TIME DETECTION OF JAK2 V617F IN THE MYELOPROLIFERATIVE DISORDERS
    Goday-Fernandez, A.
    Boyd, E. M.
    Bench, A. J.
    Erber, W. N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 302 - 302
  • [16] Rapid detection of JAK2 V617F mutation in myeloproliferative disorders
    Mir, Rashid
    AbuDuhier, Faisal M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [17] JAK2 V617F mutation in philadelphia chromosome-positive myeloproliferative disease
    Yun, Hyeong-Kee
    Shin, Myung-Geun
    Moon, Chang-Jin
    Kim, Hye-Ran
    Lee, Sun-Young
    Kim, Hyeoung-Joon
    Cho, Duck
    Shin, Jong-Hee
    Suh, Soon-Pal
    Ryang, Dong-Wook
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2007, 29 : 112 - 112
  • [18] Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders
    Langabeer, S. E.
    Ainle, F. Ni
    Conneally, E.
    Lawler, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2007, 176 (02) : 105 - 109
  • [19] Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders
    S. E. Langabeer
    F. Ni Ainle
    E. Conneally
    M. Lawler
    Irish Journal of Medical Science, 2007, 176 : 105 - 109
  • [20] Analysis of JAK2 V617F mutation in Tunisian patients with myeloproliferative neoplasms
    Chadi, Soumaya
    Dhaouadi, Tarak
    Sfar, Imen
    Baccouche, Hela
    Nabli, Rym
    Ben Romdhane, Neila
    Ben Abdallah, Taieb
    Gorgi, Yousr
    EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
12345